|
|
Upcoming Events week of Nov 1- Oct 7 |
|
|
| Nov 4 |
CCB Fall Seminar Series – 12P, 201 Erma Byrd
Josh Farris, PhD Candidate
Regulation of Anoikis through Metabolic Reprogramming during EMT or GRHL2-mediated MET |
| Nov 6 |
EMT Program meeting – 12P – 1P, G801 |
|
|
|
|
WVU Cancer Institute: New name projects unified identity
The WVU Cancer Institute is now our official new name, which represents a unified identity for cancer care, research, prevention and service.
Read more
WVU medical director disagrees with new American Cancer Society guidelines on annual mammorgrams
Ginger Layne, MD, medical director of the Betty Puskar Breast Care Center, shared her expertise on the new ACS guidelines on annual mammograms with WV MetroNews.
Read more
|
|
Text to Donate Reminder
Please remember to Text “WVUCare to 41444 to donate any amount throughout the month of October!
Your money will go toward breast cancer education and research at the MBRCC. Please share the Text to Donate information with your friends and colleagues too! |
Breast cancer survivors honored at Afternoon of Enlightenment
Healthcare providers at WVU Medicine and the WVU Cancer Institute at the Mary Babb Randolph Cancer Center paid tribute to more than 200 breast cancer survivors during the Afternoon of Enlightenment at Lakeview Resort in Morgantown on October 18.
 37-year old breast cancer survivor Dorothy Saunders (left) and newly diagnosed breast cancer survivor Andrea Neptune
Read more
CTRU offers clinical research services to WVCTSI members
The Clinical Trials Research Unit (CTRU), located on the second floor of the Blanchette Rockefeller Neurosciences Institute (BRNI) on the WVU Health Sciences Center campus, offers clinical research services that includes: study coordination, protocol development support, IRB application support, database management, and budgetary/accounting services. Three subject exam rooms, a reception/waiting area, and meeting room designed to help support clinical research are also available. Please contact John Naim, PhD, CTRU director, for more information regarding services and availability of space at 304-293-4944 or email jnaim@hsc.wvu.edu
Panera Bread sold dozens of pink ribbon bagels outside of the HSC Cafeteria this Thursday morning
 A portion of the proceeds will benefit Susan G. Komen WV, which provides financial support to Bonnie’s Bus.
November 7 marks 3rd annual International Day of Medical Physics
As November 7 marks the 3rd annual International Day of Medical Physics, we want to recognize the medical physicists in our radiation oncology department at West Virginia University Medicine –John Kralik, Josh Hack, Nicole Bunda-Randall and Ramon Alfredo Siochi, PhD, director of medical physics.
Read more
Two dogs and a cat win CTRU Halloween pet contest
The Clinical Trials Research Unit held its first annual best Halloween pet contest. There were 17 entries for two categories - best costume and best fall splendor. There was a tie for best pet costume: Bobbie Spear and her grand-dog Beans (WVU pride) and Melissa Himes and her dog Kaylee (Captain America). Fall splendor winner was Laila Wallace and her cat Bella.
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
Loss of adipocyte VEGF impairs endurance exercise capacity in mice.
Zachwieja, N. J., O'Connell, G. C., Stricker, J. C., Allen, J., Vona-Davis, L. C., Bryner, R., Mandler, W., and Mark, Olfert, I. Med Sci Sports Exerc. 2015;47(11):2329-2339.
Read More
Study design, intervention, and baseline characteristics of a group randomized trial involving a faith-based healthy eating and physical activity intervention (Walk by Faith) to reduce weight and cancer risk among overweight and obese Appalachian adults.
Baltic, R. D., Weier, R. C., Katz, M. L., Kennedy, S., Lengerich, E. J., Lesko, S. M., Reese, D., Roberto, K. A., Schoenberg, N. E., Young, G. S., Dignan, M. B., and Paskett, E. D. Contemp Clin Trials. 2015;44:1-10.
Read More
NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer.
Adkins, C. E., Nounou, M. I., Hye, T., Mohammad, A. S., Terrell-Hall, T., Mohan, N. K., Eldon, M. A., Hoch, U., and Lockman, P. R. BMC Cancer. 2015;15(1):685.
Read More
Molecular determinants of blood-brain barrier permeation.
Geldenhuys, W. J., Mohammad, A. S., Adkins, C. E., and Lockman, P. R. Ther Deliv. 2015;6(8):961-971.
Read More |
|
|
|
|
|
NIH Notices
NIH Requests for Applications
NIH Program Announcements
- Examination of Survivorship Care Planning Efficacy and Impact (R21)
(PA-16-011)
National Cancer Institute
Application Receipt Date(s): January 07, 2019
- Examination of Survivorship Care Planning Efficacy and Impact (R01)
(PA-16-012)
National Cancer Institute
Application Receipt Date(s): January 07, 2019
- Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp)
(PA-16-013)
National Center for Complementary and Integrative Health
Application Receipt Date(s): April 1 and September 1, 2016-2018 by 5:00 PM local time of applicant organization.
- Innovation Corps (I-Corps) at NIH Program for NIH and CDC Phase I Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grantees (Admin Supp )
(PA-16-019)
National Cancer Institute
et al.
Application Receipt Date(s): December 10, 2015; March 21, 2016, by 5:00 PM local time of applicant organization.
- Innovative Questions in Symptom Science and Genomics (R15)
(PA-16-022)
National Institute of Nursing Research
Application Receipt Date(s): Multiple dates, see announcement.
- Innovative Questions in Symptom Science and Genomics (R21)
(PA-16-023)
National Institute of Nursing Research
Application Receipt Date(s): Multiple dates, see announcement.
- Innovative Questions in Symptom Science and Genomics (R01)
(PA-16-024)
National Institute of Nursing Research
Application Receipt Date(s): Multiple dates, see announcement.
- Novel Genomic Technology Development (R01)
(PAR-16-014)
National Human Genome Research Institute
Application Receipt Date(s): January 14, 2016; October 31, 2016; October 31, 2017, by 5:00 PM local time of applicant organization.
- Novel Genomic Technology Development (R21)
(PAR-16-015)
National Human Genome Research Institute
Application Receipt Date(s): January 14, 2016; October 31, 2016; October 31, 2017, by 5:00 PM local time of applicant organization.
- Novel Genomic Technology Development (R43/R44)
(PAR-16-016)
National Human Genome Research Institute
Application Receipt Date(s): January 14, 2016; October 31, 2016; October 31, 2017, by 5:00 PM local time of applicant organization.
- Novel Genomic Technology Development Direct to Phase II SBIR (R44)
(PAR-16-017)
National Human Genome Research Institute
Application Receipt Date(s): January 14, 2016; October 31, 2016, by 5:00 PM local time of applicant organization.
Other Funding/Opportunities
|
|
|
|
| Nov 8 |
Vera Bradley Bingo Relay for Life fundraiser – 1P, doors open at noon, HSC, Room 1905
Read more |
| Nov 11 |
CCB Fall Seminar Series 2015 – 12P - 1P, HSN Room # 2157
Jody Rosenblatt, PhD
Huntsman Cancer Institute - University of Utah
Hijacking epithelial cell extrusion to drive tumor formation and invasion |
| Nov 13 |
CCB faculty meeting – 1P – 2P, John Jones 2
Alexandra Elliot will conduct biosafety training for PI’s.
|
| Nov 19 |
Statler Research Office Seminar Series – 12P – 1P, G112 ESB
DoD R&D Opportunities & Innovation at WVU
Mr. Matt Harbaugh, Assoc. VP and Executive Director at
WVU Innovation Corporation
Refreshments will be served. RSVP Nancy Yost at 293-3178 |
| Nov 20 |
Allen Lung Program meeting – 12P – 1P, G801 |
| Dec 2 |
CCB Fall Seminar Series 2015 – 12P - 1P, Room # 2157
Valery Grdzelishvili, PhD
University of North Carolina at Charlotte
Vesicular stomatitis virus as an oncolytic agent against pancreatic cancer |
|
|
|
|
|
|
